{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:39:14Z","timestamp":1791189554073,"version":"4.1.0"},"reference-count":71,"publisher":"EDP Sciences","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologie Aujourd'hui"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1051\/jbio\/2012015","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T08:20:30Z","timestamp":1341303630000},"page":"135-143","source":"Crossref","is-referenced-by-count":4,"title":["Remodelage de la matrice extracellulaire dans les valves atteintes de st\u00e9nose aortique"],"prefix":"10.1051","volume":"206","author":[{"given":"Najlah","family":"Kochtebane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Choqueux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2012,7,4]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Aikawa E., Aikawa M., Libby P., Figueiredo J.L., Rusanescu G., Iwamoto Y., Fukuda D., Kohler R.H., Shi G.P., Jaffer F.A., Weissleder R., Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.Circulation, 2009, 119, 1785\u20131794.","DOI":"10.1161\/CIRCULATIONAHA.108.827972"},{"key":"R2","unstructured":"Barrett A.J., Proteolytic enzymes: serine and cysteine peptidases.Methods in Enzymology, 1994, Academic Press, Toronto, 244."},{"key":"R3","unstructured":"Barrett A.J., Proteolytic enzymes: aspartic and metallo peptidases.Methods in Enzymology, 1995, Academic Press, Toronto, 248."},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Bobik A., Tkachuk V., Metalloproteinases and plasminogen activators in vessel remodeling.Curr Hypertens Rep, 2003, 5, 466\u2013472.","DOI":"10.1007\/s11906-003-0054-5"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Bonnefoy A., Legrand C., Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase.Thromb Res, 2000, 98, 323\u2013332.","DOI":"10.1016\/S0049-3848(99)00242-X"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Castellino F.J., Ploplis V.A., Structure and function of the plasminogen\/plasmin system.Thromb Haemost, 2005, 93, 647\u2013654.","DOI":"10.1160\/TH04-12-0842"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Chain D., Kreizman T., Shapira H., Shaltiel S., Plasmin cleavage of vitronectin. Identification of the site and consequent attenuation in binding plasminogen activator inhibitor-1.FEBS Lett, 1991, 285, 251\u2013256.","DOI":"10.1016\/0014-5793(91)80810-P"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Chan K.L., Is aortic stenosis a preventable disease?J Am Coll Cardiol, 2003, 42, 593\u2013599.","DOI":"10.1016\/S0735-1097(03)00786-1"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Chen J.H., Simmons C.A., Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues.Circ Res, 2011, 108, 1510\u20131524.","DOI":"10.1161\/CIRCRESAHA.110.234237"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Cornelius L.A., Nehring L.C., Harding E., Bolanowski M., Welgus H.G., Kobayashi D.K., Pierce R.A., Shapiro S.D., Matrix metalloproteinases generate angiostatin: effects on neovascularization.J Immunol, 1998, 161, 6845\u20136852.","DOI":"10.4049\/jimmunol.161.12.6845"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Cowell S.J., Newby D.E., Boon N.A., Elder A.T., Calcific aortic stenosis: same old story?Age Ageing, 2004, 33, 538\u2013544.","DOI":"10.1093\/ageing\/afh175"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Dzwonek J., Rylski M., Kaczmarek L., Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain.FEBS Lett, 2004, 567, 129\u2013135.","DOI":"10.1016\/j.febslet.2004.03.070"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Edep M.E., Shirani J., Wolf P., Brown D.L., Matrix metalloproteinase expression in nonrheumatic aortic stenosis.Cardiovasc Pathol, 2000, 9, 281\u2013286.","DOI":"10.1016\/S1054-8807(00)00043-0"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Ellis V., Murphy G., Cellular strategies for proteolytic targeting during migration and invasion.FEBS Lett, 2001, 506, 1\u20135.","DOI":"10.1016\/S0014-5793(01)02845-9"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Eriksen H.A., Satta J., Risteli J., Veijola M., Vare P., Soini Y., Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis.Atherosclerosis, 2006, 189, 91\u201398.","DOI":"10.1016\/j.atherosclerosis.2005.11.034"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Fernandez-Monreal M., Lopez-Atalaya J.P., Benchenane K., Cacquevel M., Dulin F., Le Caer J.P., Rossier J., Jarrige A.C., Mackenzie E.T., Colloc\u2019h N., Ali C., Vivien D., Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling.J Biol Chem, 2004, 279, 50850\u201350856.","DOI":"10.1074\/jbc.M407069200"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Fondard O., Detaint D., Iung B., Choqueux C., Adle-Biassette H., Jarraya M., Hvass U., Couetil J.P., Henin D., Michel J.B., Vahanian A., Jacob M.P., Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.Eur Heart J, 2005, 26, 1333\u20131341.","DOI":"10.1093\/eurheartj\/ehi248"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Fontaine V., Jacob M.P., Houard X., Rossignol P., Plissonnier D., Angles-Cano E., Michel J.B., Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.Am J Pathol, 2002, 161, 1701\u20131710.","DOI":"10.1016\/S0002-9440(10)64447-1"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Freeman R.V., Otto C.M., Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.Circulation, 2005, 111, 3316\u20133326.","DOI":"10.1161\/CIRCULATIONAHA.104.486738"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Goldbarg S.H., Elmariah S., Miller M.A., Fuster V., Insights into degenerative aortic valve disease.J Am Coll Cardiol, 2007, 50, 1205\u20131213.","DOI":"10.1016\/j.jacc.2007.06.024"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Grande-Allen K.J., Osman N., Ballinger M.L., Dadlani H., Marasco S., Little P.J., Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease.Cardiovasc Res, 2007, 76, 19\u201328.","DOI":"10.1016\/j.cardiores.2007.05.014"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Hakuno D., Kimura N., Yoshioka M., Mukai M., Kimura T., Okada Y., Yozu R., Shukunami C., Hiraki Y., Kudo A., Ogawa S., Fukuda K., Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents.J Clin Invest, 2010, 120, 2292\u20132306.","DOI":"10.1172\/JCI40973"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Helske S., Syvaranta S., Kupari M., Lappalainen J., Laine M., Lommi J., Turto H., Mayranpaa M., Werkkala K., Kovanen P.T., Lindstedt K.A., Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves.Eur Heart J, 2006a, 27, 1495\u20131504.","DOI":"10.1093\/eurheartj\/ehi706"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Helske S., Syvaranta S., Lindstedt K.A., Lappalainen J., Oorni K., Mayranpaa M.I., Lommi J., Turto H., Werkkala K., Kupari M., Kovanen P.T., Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves.Arterioscler Thromb Vasc Biol, 2006b, 26, 1791\u20131798.","DOI":"10.1161\/01.ATV.0000228824.01604.63"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Hinton R.B., Lincoln J., Deutsch G.H., Osinska H., Manning P.B., Benson D.W., Yutzey K.E., Extracellular matrix remodeling and organization in developing and diseased aortic valves.Circ Res, 2006, 98, 1431\u20131438.","DOI":"10.1161\/01.RES.0000224114.65109.4e"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Hynes R.O., Zhao Q., The evolution of cell adhesion.J Cell Biol, 2000, 150, F89\u201396.","DOI":"10.1083\/jcb.150.2.F89"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Iung B., Baron G., Butchart E.G., Delahaye F., Gohlke-Barwolf C., Levang O.W., Tornos P., Vanoverschelde J.L., Vermeer F., Boersma E., Ravaud P., Vahanian A., A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.Eur Heart J, 2003, 24, 1231\u20131243.","DOI":"10.1016\/S0195-668X(03)00201-X"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Jacob M.P., Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions.Biomed Pharmacother, 2003, 57, 195\u2013202.","DOI":"10.1016\/S0753-3322(03)00065-9"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Jian B., Jones P.L., Li Q., Mohler E.R., Schoen F.J., Levy R.J., Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis.Am J Pathol, 2001, 159, 321\u2013327.","DOI":"10.1016\/S0002-9440(10)61698-7"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Jian B., Narula N., Li Q.Y., Mohler E.R., Levy R.J., Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis.Ann Thorac Surg, 2003, 75, 457\u2013465; discussion 465\u2013466.","DOI":"10.1016\/S0003-4975(02)04312-6"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Jiang Y., Goldberg I.D., Shi Y.E., Complex roles of tissue inhibitors of metalloproteinases in cancer.Oncogene, 2002, 21, 2245\u20132252.","DOI":"10.1038\/sj.onc.1205291"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Jourquin J., Tremblay E., Decanis N., Charton G., Hanessian S., Chollet A.M., Le Diguardher T., Khrestchatisky M., Rivera S., Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.Eur J Neurosci, 2003, 18, 1507\u20131517.","DOI":"10.1046\/j.1460-9568.2003.02876.x"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Kaden J.J., Vocke D.C., Fischer C.S., Grobholz R., Brueckmann M., Vahl C.F., Hagl S., Haase K.K., Dempfle C.E., Borggrefe, M., Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.Z Kardiol, 2004, 93, 124\u2013130.","DOI":"10.1007\/s00392-004-1021-0"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Kaden J.J., Dempfle C.E., Grobholz R., Fischer C.S., Vocke D.C., Kilic R., Sarikoc A., Pinol R., Hagl S., Lang S., Brueckmann M., Borggrefe M., Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.Cardiovasc Pathol, 2005, 14, 80\u201387.","DOI":"10.1016\/j.carpath.2005.01.002"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Kochtebane N., Choqueux C., Passefort S., Nataf P., Messika-Zeitoun D., Bartagi A., Michel J.B., Angles-Cano E., Jacob M. P., Plasmin induces apoptosis of aortic valvular myofibroblasts.J Pathol, 2010, 221, 37\u201348.","DOI":"10.1002\/path.2681"},{"key":"R36","unstructured":"Latif N., Sarathchandra P., Taylor P.M., Antoniw J., Yacoub M.H., Localization and pattern of expression of extracellular matrix components in human heart valves.J Heart Valve Dis, 2005, 14, 218\u2013227."},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Liberman M., Bassi E., Martinatti M.K., Lario F.C., Wosniak J., Pomerantzeff P.M., Laurindo F.R., Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification.Arterioscler Thromb Vasc Biol, 2008, 28, 463\u2013470.","DOI":"10.1161\/ATVBAHA.107.156745"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Lijnen H.R., Ugwu F., Bini A., Collen D., Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).Biochemistry, 1998, 37, 4699\u20134702.","DOI":"10.1021\/bi9731798"},{"key":"R39","unstructured":"Lijnen H.R., Elements of the fibrinolytic system.Ann N Y Acad Sci. 2001a, 936, 226\u2013236."},{"key":"R40","doi-asserted-by":"crossref","unstructured":"Lijnen H.R., Plasmin and matrix metalloproteinases in vascular remodeling.Thromb Haemost, 2001b, 86, 324\u2013333.","DOI":"10.1055\/s-0037-1616230"},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Liotta L.A., Goldfarb R.H., Terranova V.P., Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin.Thromb Res, 1981, 21, 663\u2013673.","DOI":"10.1016\/0049-3848(81)90268-1"},{"key":"R42","doi-asserted-by":"crossref","unstructured":"Mazzone A., Epistolato M.C., De Caterina R., Storti S., Vittorini S., Sbrana S., Gianetti J., Bevilacqua S., Glauber M., Biagini A., Tanganelli P., Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis.J Am Coll Cardiol, 2004, 43, 1670\u20131676.","DOI":"10.1016\/j.jacc.2003.12.041"},{"key":"R43","doi-asserted-by":"crossref","unstructured":"McCawley L.J., Matrisian L.M., Matrix metalloproteinases: they\u2019re not just for matrix anymore!Curr Opin Cell Biol, 2001, 13, 534\u2013540.","DOI":"10.1016\/S0955-0674(00)00248-9"},{"key":"R44","doi-asserted-by":"crossref","unstructured":"McDonald P.C., Wilson J.E., McNeill S., Gao M., Spinelli J.J., Rosenberg F., Wiebe H., McManus B.M., The challenge of defining normality for human mitral and aortic valves: geometrical and compositional analysis.Cardiovasc Pathol, 2002, 11, 193\u2013209.","DOI":"10.1016\/S1054-8807(01)00102-8"},{"key":"R45","doi-asserted-by":"crossref","unstructured":"Meilhac O., Ho-Tin-Noe B., Houard X., Philippe M., Michel J.B., Angles-Cano E., Pericellular plasmin induces smooth muscle cell anoikis.FASEB J, 2003, 17, 1301\u20131303.","DOI":"10.1096\/fj.02-0687fje"},{"key":"R46","doi-asserted-by":"crossref","unstructured":"Michel J.B., Anoikis in the cardiovascular system: known and unknown extracellular mediators.Arterioscler Thromb Vasc Biol, 2003, 23, 2146\u20132154.","DOI":"10.1161\/01.ATV.0000099882.52647.E4"},{"key":"R47","doi-asserted-by":"crossref","unstructured":"Miller J.D., Chu Y., Brooks R.M., Richenbacher W.E., Pena-Silva R., Heistad D.D., Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans.J Am Coll Cardiol, 2008, 52, 843\u2013850.","DOI":"10.1016\/j.jacc.2008.05.043"},{"key":"R48","doi-asserted-by":"crossref","unstructured":"Mohler E.R., Gannon F., Reynolds C., Zimmerman R., Keane M.G., Kaplan F.S., Bone formation and inflammation in cardiac valves.Circulation, 2001, 103, 1522\u20131528.","DOI":"10.1161\/01.CIR.103.11.1522"},{"key":"R49","doi-asserted-by":"crossref","unstructured":"Mondino A., Blasi F., uPA and uPAR in fibrinolysis, immunity and pathology.Trends Immunol, 2004, 25, 450\u2013455.","DOI":"10.1016\/j.it.2004.06.004"},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Montgomery A.M., Sabzevari H., Reisfeld R.A., Production and regulation of gelatinase B by human T-cells.Biochim Biophys Acta, 1993, 1176, 265\u2013268.","DOI":"10.1016\/0167-4889(93)90054-S"},{"key":"R51","doi-asserted-by":"crossref","unstructured":"Nagase H., Woessner J.F., Matrix metalloproteinases.J Biol Chem, 1999, 274, 21491\u201321494.","DOI":"10.1074\/jbc.274.31.21491"},{"key":"R52","doi-asserted-by":"crossref","unstructured":"Nelson A.R., Fingleton B., Rothenberg M.L., Matrisian L.M., Matrix metalloproteinases: biologic activity and clinical implications.J Clin Oncol, 2000, 18, 1135\u20131149.","DOI":"10.1200\/JCO.2000.18.5.1135"},{"key":"R53","doi-asserted-by":"crossref","unstructured":"Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M., Burden of valvular heart diseases: a population-based study.Lancet, 2006, 368, 1005\u20131011.","DOI":"10.1016\/S0140-6736(06)69208-8"},{"key":"R54","doi-asserted-by":"crossref","unstructured":"O\u2019Brien K.D., Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more).Arterioscler Thromb Vasc Biol, 2006, 26, 1721\u20131728.","DOI":"10.1161\/01.ATV.0000227513.13697.ac"},{"key":"R55","doi-asserted-by":"crossref","unstructured":"O\u2019Brien K.D., Reichenbach D.D., Marcovina S.M., Kuusisto J., Alpers C.E., Otto C.M., Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of \u201cdegenerative\u201d valvular aortic stenosis.Arterioscler Thromb Vasc Biol, 1996, 16, 523\u2013532.","DOI":"10.1161\/01.ATV.16.4.523"},{"key":"R56","doi-asserted-by":"crossref","unstructured":"Olsson M., Thyberg J., Nilsson J., Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.Arterioscler Thromb Vasc Biol, 1999, 19, 1218\u20131222.","DOI":"10.1161\/01.ATV.19.5.1218"},{"key":"R57","doi-asserted-by":"crossref","unstructured":"Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., O\u2019Brien K.D., Characterization of the early lesion of \u201cdegenerative\u201d valvular aortic stenosis. Histological and immunohistochemical studies.Circulation, 1994, 90, 844\u2013853.","DOI":"10.1161\/01.CIR.90.2.844"},{"key":"R58","doi-asserted-by":"crossref","unstructured":"Owen C.A., Campbell E.J., The cell biology of leukocyte-mediated proteolysis.J Leukoc Biol, 1999, 65, 137\u2013150.","DOI":"10.1002\/jlb.65.2.137"},{"key":"R59","doi-asserted-by":"crossref","unstructured":"Pepper M.S., Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.Arterioscler Thromb Vasc Biol, 2001, 21, 1104\u20131117.","DOI":"10.1161\/hq0701.093685"},{"key":"R60","doi-asserted-by":"crossref","unstructured":"Rajamannan N.M., Subramaniam M., Rickard D., Stock S.R., Donovan J., Springett M., Orszulak T., Fullerton D.A., Tajik A.J., Bonow R.O., Spelsberg T., Human aortic valve calcification is associated with an osteoblast phenotype.Circulation, 2003, 107, 2181\u20132184.","DOI":"10.1161\/01.CIR.0000070591.21548.69"},{"key":"R61","doi-asserted-by":"crossref","unstructured":"Sacks M.S., David Merryman W., Schmidt D.E., On the biomechanics of heart valve function.J Biomech, 2009, 42, 1804\u20131824.","DOI":"10.1016\/j.jbiomech.2009.05.015"},{"key":"R62","doi-asserted-by":"crossref","unstructured":"Satta J., Melkko J., Pollanen R., Tuukkanen J., Paakko P., Ohtonen P., Mennander A., Soini Y., Progression of human aortic valve stenosis is associated with tenascin-C expression.J Am Coll Cardiol, 2002, 39, 96\u2013101.","DOI":"10.1016\/S0735-1097(01)01705-3"},{"key":"R63","doi-asserted-by":"crossref","unstructured":"Satta J., Oiva J., Salo T., Eriksen H., Ohtonen P., Biancari F., Juvonen T.S., Soini Y., Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis.Ann Thorac Surg, 2003, 76, 681\u2013688; discussion 688.","DOI":"10.1016\/S0003-4975(03)00529-0"},{"key":"R64","doi-asserted-by":"crossref","unstructured":"Schedin P., Strange R., Mitrenga T., Wolfe P., Kaeck M., Fibronectin fragments induce MMP activity in mouse mammary epithelial cells: evidence for a role in mammary tissue remodeling.J Cell Sci, 2000, 113, 795\u2013806.","DOI":"10.1242\/jcs.113.5.795"},{"key":"R65","doi-asserted-by":"crossref","unstructured":"Sidenius N., Blasi F., The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.Cancer Metastasis Rev, 2003, 22, 205\u2013222.","DOI":"10.1023\/A:1023099415940"},{"key":"R66","doi-asserted-by":"crossref","unstructured":"Soini Y., Satta J., Maatta M., Autio-Harmainen H., Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.J Pathol, 2001, 194, 225\u2013231.","DOI":"10.1002\/path.850"},{"key":"R67","doi-asserted-by":"crossref","unstructured":"Soini Y., Salo T., Satta J., Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis.Hum Pathol, 2003, 34, 756\u2013763.","DOI":"10.1016\/S0046-8177(03)00245-4"},{"key":"R68","doi-asserted-by":"crossref","unstructured":"Ugwu F., Van Hoef B., Bini A., Collen D., Lijnen H.R., Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).Biochemistry, 1998, 37, 7231\u20137236.","DOI":"10.1021\/bi9728708"},{"key":"R69","doi-asserted-by":"crossref","unstructured":"Visse R., Nagase H., Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.Circ Res, 2003, 92, 827\u2013839.","DOI":"10.1161\/01.RES.0000070112.80711.3D"},{"key":"R70","doi-asserted-by":"crossref","unstructured":"Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S., Chapman H.A., Identification of the urokinase receptor as an adhesion receptor for vitronectin.J Biol Chem, 1994, 269, 32380\u201332388.","DOI":"10.1016\/S0021-9258(18)31646-6"},{"key":"R71","doi-asserted-by":"crossref","unstructured":"Yepes M., Lawrence D.A., New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system.Exp Biol Med (Maywood), 2004, 229, 1097\u20131104.","DOI":"10.1177\/153537020422901103"}],"container-title":["Biologie Aujourd'hui"],"original-title":[],"link":[{"URL":"http:\/\/www.biologie-journal.org\/10.1051\/jbio\/2012015\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T01:30:29Z","timestamp":1687570229000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biologie-journal.org\/10.1051\/jbio\/2012015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":71,"journal-issue":{"issue":"2"},"alternative-id":["jbio2012015"],"URL":"https:\/\/doi.org\/10.1051\/jbio\/2012015","relation":{},"ISSN":["2105-0678","2105-0686"],"issn-type":[{"value":"2105-0678","type":"print"},{"value":"2105-0686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}